OR WAIT null SECS
Companies to release variety of options for this sector.
Stevanato Group, a provider of drug containment and delivery solutions, is partnering up with Transcoject, a medical device and pharma packaging company. The collaboration features the addition of cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) pre-fillable syringes (PFS) to Stevanato’s current portfolio.
As alluded to previously, by integrating Transcoject’s technological knowledge with its experience in drug containment, the company will be able to offer pre-fillable syringes in glass via both COP and COC polymers. Reportedly, the products’ versatility and customizability can make them ideal for meeting many compliance requirements, and they can be seamlessly integrated into existing fill-finish lines.
Stevanato expects the new technology to be ready by 2025, and format options will be adjustable to meet clients’ specific requirements. A staked-needle PFS version is expected to be launched in the following years.
“The addition of COP and COC pre-fillable syringes will uniquely position Stevanato Group to be able to offer both COC, COP, and glass options in the market, empowering customers to select the best-suited solution to fit their needs from multiple options,” says Mauro Stocchi, Stevanato Group’s chief business officer. “This is a testament to Stevanato Group’s focus on meeting market needs through an integrated and comprehensive portfolio of drug delivery solutions.”
Read more about the syringe technology here.